Principal Financial Group Inc. Raises Stock Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Principal Financial Group Inc. grew its stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 6.2% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 586,190 shares of the company's stock after acquiring an additional 34,266 shares during the quarter. Principal Financial Group Inc. owned about 0.68% of Pediatrix Medical Group worth $8,494,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of MD. Nomura Asset Management Co. Ltd. boosted its stake in Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock valued at $33,000 after buying an additional 1,220 shares in the last quarter. GAMMA Investing LLC raised its position in Pediatrix Medical Group by 219.5% in the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares during the last quarter. AlphaQuest LLC raised its position in Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company's stock valued at $66,000 after purchasing an additional 2,012 shares during the last quarter. Tower Research Capital LLC TRC raised its position in Pediatrix Medical Group by 218.0% in the fourth quarter. Tower Research Capital LLC TRC now owns 7,445 shares of the company's stock valued at $98,000 after purchasing an additional 5,104 shares during the last quarter. Finally, Squarepoint Ops LLC acquired a new position in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $132,000. 97.71% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the company. UBS Group lowered their price objective on Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research note on Monday, May 12th. Truist Financial lowered their price objective on Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research note on Friday, April 11th. Finally, Macquarie upped their price objective on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research note on Thursday, May 8th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $16.67.

Pediatrix Medical Group Stock Performance

Pediatrix Medical Group stock traded down $0.01 during mid-day trading on Wednesday, reaching $12.80. 117,289 shares of the company's stock were exchanged, compared to its average volume of 716,749. The company has a quick ratio of 1.81, a current ratio of 1.81 and a debt-to-equity ratio of 0.75. The business's fifty day simple moving average is $13.93 and its 200 day simple moving average is $13.88. Pediatrix Medical Group, Inc. has a one year low of $7.07 and a one year high of $17.67. The firm has a market capitalization of $1.10 billion, a PE ratio of -12.67, a P/E/G ratio of 0.89 and a beta of 1.25.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping the consensus estimate of $0.25 by $0.08. Pediatrix Medical Group had a positive return on equity of 17.43% and a negative net margin of 4.17%. The business had revenue of $458.36 million for the quarter, compared to the consensus estimate of $451.44 million. During the same period in the previous year, the company posted $0.20 earnings per share. The company's revenue for the quarter was down 7.4% compared to the same quarter last year. On average, sell-side analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.